BCRX
NASDAQ · Biotechnology
Biocryst Pharmaceuticals Inc
$7.69
+0.06 (+0.79%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+759.8% upside
Low Target
$46.17
Average Target
$66.12
High Target
$78.89
Current Price
$7.69
Current
$7.69
$7.69
Target
$66.12
$66.12
$46.17
$66.12 avg
$78.89
Scenario Analysis
Bear Case
$46.17
500.4%
Low target
Base Case
$66.12
+759.8%
Avg target
Bull Case
$78.89
+925.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$11.22
-31.5% from high
52-Week Low
$6.23
+23.4% from low
Target vs 52W High
$66.12
+489.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |